Public Pricelist
  1. All Products
  2. Afluria Influenza Vaccine 2025-2026 Formula

Afluria Influenza Vaccine 2025-2026 Formula

Afluria® Quadrivalent is a seasonal influenza vaccine indicated for active immunization against influenza virus subtypes A and B strains contained in the 2025–2026 Northern Hemisphere formula. This inactivated vaccine is approved for patients 6 months of age and older, helping to reduce the risk of flu-related illness and complications.

  • This item is refrigerated
  • This item is RX
Item #
https://www.smartmedicalsolutions.com/web/image/product.template/1964/image_1920?unique=bc5d6a5

Not Available For Sale

  • Select Presentation:

This combination does not exist.



Contact Us

Seasonal Item - No Returns

  • Formulation Year: 2025–2026
  • Type: Inactivated Influenza Vaccine, Quadrivalent
  • Strains Included: 2 Influenza A strains & 2 Influenza B strains (as recommended by WHO/CDC for the 2025–2026 season)
  • Presentation:
    – Prefilled syringe (0.5 mL) – no preservative
    – Multi-dose vial (5 mL) – contains thimerosal
  • Administration Route: Intramuscular (IM)
  • Age Indication: 6 months and older
  • Manufacturer: CSL Seqirus

Note: Always consult a healthcare provider for dosing by age group and patient history. Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.

Seqirus

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Specifications

Select Presentation: Multi-Dose Vial, 10-Dose, 5mL (6 moths & older) or 10 Single Dose Pre-Filled Syringes, 0.5mL (3 Years & Older)